Sign In
Free Newsletter
Senseonics gets Medicare payment rate decision, has Q3 loss
Health care providers will be able to bill Medicare directly for inserting a Germantown company's implantable blood sugar monitor into patients under new federal policies for 2020.
Senseonics gains 2 large US insurers for implantable monitor
Senseonics Holdings Inc., the Germantown company that developed the only long-term implantable system for monitoring blood sugar, has had its system approved by more insurance carriers.
Senseonics begins US 180-day study of implantable monitor
The Germantown company that developed the only long-term implantable system for monitoring blood sugar has begun a clinical study to study its system when implanted for twice as long as is now allowed in the United States.
Senseonics aims to boost insurance coverage by publishing data
A Germantown company that developed the only long-term implantable system for monitoring blood sugar has published data it hopes will convince more insurers to cover the system for patients with diabetes.
